Furosemide
Furosemide Tablets
Approved
Approval ID
30f13263-461f-4363-898d-291fc1467dd0
Product Type
PRESCRIPTION ANIMAL DRUG LABEL
Effective Date
Apr 29, 2025
Manufacturers
FDA
Covetrus North America
DUNS: 603750329
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Furosemide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code11695-0091
Application NumberNADA129034
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationORAL
Effective DateApril 29, 2025
FDA Product Classification
INGREDIENTS (6)
FUROSEMIDEActive
Quantity: 50 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
Furosemide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code11695-0090
Application NumberNADA129034
Product Classification
M
Marketing Category
C73593
G
Generic Name
Furosemide
Product Specifications
Route of AdministrationORAL
Effective DateApril 29, 2025
FDA Product Classification
INGREDIENTS (6)
FUROSEMIDEActive
Quantity: 12.5 mg in 1 1
Code: 7LXU5N7ZO5
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT